Private pre-clinical biotechnology company developing a protein-based artificial retina and a layer-by-layer microgravity manufacturing process for regulated biomaterial production.
Private pre-clinical biotechnology company developing a protein-based artificial retina and a layer-by-layer microgravity manufacturing process for regulated biomaterial production.
Suppliers, customers & partners
Suppliers & service providers to LambdaVision
Voyager Technologies— customer · program partner / press announcement2 connectionsTell me more
Voyager Technologies/Starlab Space supplies commercial payload space and on-orbit science park accommodation on the planned Starlab station for LambdaVision's microgravity research (announced February 2026).
Relationship research record
Voyager Technologies (parent company/operator promoting Starlab) publicly announced LambdaVision as a customer for Starlab’s on-orbit science park; Voyager / Starlab provide orbital infrastructure and program support enabling LambdaVision's in‑orbit manufacturing roadmap.
Relationship research record
Vast— mission user · strategic agreement / partner · 1 more roles4 connectionsTell me more
LambdaVision agreed with Vast to potentially use Vast's space stations for space-based manufacturing of protein-based artificial retina devices and microgravity bioprocesses; the agreement covers future usage of Vast's stations for LambdaVision experiments and manufacturing.
Relationship research record
LambdaVision hosts research on Haven-1 and Haven-2 (MoU signed June 2026).
Relationship research record
LambdaVision published an agreement with Vast to advance space‑based manufacturing of protein‑based artificial retina and microgravity bioprocesses; the agreement is presented as a commercial partnership to enable LambdaVision's on‑orbit manufacturing capabilities.
Relationship research record
Vast signed an agreement/MoU with LambdaVision to support future research and manufacturing activities aboard Haven-1 and future commercial space stations, expanding LambdaVision's access beyond the ISS (announced June 2026).
Starlab Space entered a reservation agreement with LambdaVision for payload space on its commercial space station to enable transition to long-term, scalable space-based manufacturing of artificial retinas (announced February 2026).
Relationship research record
LambdaVision customers & supported companies
None currently known.
LambdaVision program partners
Space Tango— customer / program partner · program partner · 1 more roles3 connectionsTell me more
Space Tango partnered with LambdaVision on a NASA Phase II InSPA award to advance artificial-retina manufacturing in space; Space Tango supplies the automated in-space manufacturing facilities and operations support to LambdaVision’s NASA-funded artificial retina manufacturing efforts.
Relationship research record
Space Tango is a commercial on‑orbit laboratory partner that LambdaVision is partnering with (with NASA funding) to produce and explore microgravity manufacturing of LambdaVision's protein‑based artificial retina on the ISS U.S. National Laboratory.
Relationship research record
Space Tango partners with LambdaVision to design, build, and operate a microgravity-optimized layer-by-layer deposition device and provides specialized hardware platforms plus operational guidance for artificial retina manufacturing on the ISS, supported by NASA InSPA and related awards (ongoing since at least 2018, with multiple missions and Phase II award in 2025).
Relationship research record
Helogen Corporation— mission partner / on orbit manufacturing provider · program partner2 connectionsTell me more
Helogen and LambdaVision announced a partnership to advance space‑based biomaterial manufacturing; Helogen's HEL‑IOS mission will provide operational in‑orbit manufacturing validation (flight, sample return, custody transfer and remote data) to support LambdaVision's regulated biological manufacturing needs.
Relationship research record
Helogen Corporation partnered with LambdaVision, naming it the first external manufacturing partner for low-Earth orbit production activities (announced/expanded in 2026).
LambdaVision signed an agreement (MoU) with Vast to advance space-based manufacturing of protein-based artificial retina and microgravity bioprocesses, intending to use Vast's commercial stations for microgravity research and manufacturing.
Relationship research record
Government awards & missions
Seraphim Space— seed-round-investorTell me more
Seraphim Space provided additional investment support in LambdaVision's $7 million seed round. · Seed financing for LambdaVision's space-enabled retinal-implant manufacturing development.
LambdaVision names Seraphim Space as an additional supporter of its $7 million seed round.
investment organization
Aurelia Foundry Fund— seed-round-co-lead-investorTell me more
Aurelia Foundry Fund co-led LambdaVision's $7 million seed round, providing capital for continued artificial-retina and space-biomanufacturing development. · $7 million seed financing supporting operations into 2027.
LambdaVision identifies Aurelia Foundry Fund as a co-lead of the seed round.
investment organization
Seven Seven Six— seed-round-co-lead-investorTell me more
Seven Seven Six co-led LambdaVision's $7 million seed round, providing capital for the company's artificial-retina and space-based manufacturing development. · $7 million seed financing supporting operations into 2027.
LambdaVision identifies Seven Seven Six as a co-lead of its $7 million seed round.
investment organization
MassChallenge Technology in Space Prize— startup-microgravity-research-award-recipientTell me more
The MassChallenge Technology in Space Prize supported LambdaVision's initial ISS National Laboratory investigation of its retinal implant. · Initial ISS research to assess whether microgravity improves the uniformity and performance of the artificial-retina protein/polymer layers.
The ISS National Lab directly states that LambdaVision's initial ISS investigation was supported by this award program.
award program
NASA— government-research-funding-and-commercialization-award-sponsorTell me more
NASA awarded funding to LambdaVision, including a $5 million commercialization award shared with Space Tango and a 2024 NASA SBIR Phase II award for on-orbit solution recycling and scaled artificial-retina manufacturing. · ISS microgravity biomanufacturing of LambdaVision's protein-based artificial retina; SBIR Phase II project titled “On-Orbit Solution Recycling Methods to Improve Scale of Layer-by-Layer Artificial Retina Manufacturing.”
ISS National Lab reporting documents the $5 million NASA award, while the federal SBIR record identifies LambdaVision as NASA's Phase II awardee and specifies the contract period and scope.
government agency
Explore LambdaVision in context
← Suppliers to LambdaVision4 companies · Browse profiles
Highlighted companies match the selected filters. Smaller translucent companies are their direct connections across every scale and segment. Circle size reflects connection prominence, not a ranking or valuation.
Peer companies
Other earth observation companies in data & applications.